This inventor holds 39 USPTO granted patents and 5 published patent applications and 7 EPO patents, primarily in Cancer Immunotherapy. Top assignees: The University of Tokyo, Chugai Seiyaku Kabushiki Kaisha, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1994-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ishikawa Prefecture, JP (1998)
- Ishikawa, JP (2000)
- Kanazawa, JP (1997 - 2001)
- Frederick, MD (US) (1994 - 2002)
- Matsudo, JP (2002 - 2010)
- Chiba, JP (2003 - 2015)
- Tokyo, JP (2014 - 2024)
Company Filing History:
6 out of 1,356 
5 out of 987 
5 out of 3,696 
Years Active: 1994-2026
Areas of Expertise:
Title: Innovator Spotlight: Kouji Matsushima - Pioneering Cancer Therapies
Introduction:
Kouji Matsushima, a distinguished inventor based in Tokyo, Japan, has left an indelible mark in the field of healthcare with his groundbreaking work in developing novel cancer therapies. With an impressive portfolio of 38 patents to his name, Matsushima's innovative solutions have the potential to revolutionize the way we approach cancer treatment.
Latest Patents:
One of Matsushima's latest patents, "HMGN partial peptide and cancer therapy using the same," is a significant breakthrough in the battle against cancer. This patent unveils a novel therapeutic approach that is both effective and practical in combating cancer. The peptides derived from partial regions of HMGN1, HMGN2, HMGN4, or HMGN5, offer promising anti-tumor effects, particularly when utilized in combination with immune checkpoint regulators or specific antibodies.
Career Highlights:
Having worked with esteemed institutions like The University of Tokyo and Chugai Pharmaceutical Co., Matsushima has honed his skills and expertise in the field of biotechnology and pharmaceuticals. His commitment to innovation and patient care shines through in the patents he has successfully secured, showcasing his dedication to improving cancer therapies.
Collaborations:
Throughout his career, Matsushima has collaborated with esteemed colleagues such as Yoshiro Ishiwata and Shoji Yokochi. Together, they have synergized their knowledge and skills to push the boundaries of cancer research, leading to the development of impactful therapies that hold immense promise in the fight against this complex disease.
Conclusion:
In conclusion, Kouji Matsushima's relentless pursuit of innovation in cancer therapy has cemented his status as a visionary inventor in the medical field. His patents not only reflect his scientific acumen but also underscore his unwavering commitment to improving patient outcomes. Matsushima's contributions are poised to make a lasting impact on the landscape of cancer treatment, offering hope to patients and healthcare professionals worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile